Document is current
Any future updates will be listed below
-
Authors
Santamaria, Mar
Christakis, Yiorgos
Demanuele, Charmaine
Zhang, Yao
Tuttle, Pirinka Georgiev
Mamashli, Fahimeh
Bai, Jiawei
Landman, Rogier
Chappie, Kara
Kell, Stefan
Samuelsson, John G.
Talbert, Kisha
Seoane, Leonardo
Mark Roberts, W.
Kabagambe, Edmond Kato
Capelouto, Joseph
Wacnik, Paul
Selig, Jessica
Adamowicz, Lukas
Khan, Sheraz
Mather, Robert J.
- License Information
-
More Information
Article History
Received: 2 December 2024
Accepted: 25 March 2025
First Online: 11 April 2025
Competing interests
: M.S., C.D., Y.Z., P.G.T., Y.C., J.G.S., R.L., K.C., K.T., J.S., L.A., S. Khan, and R.J.M. are employees and shareholders of Pfizer Inc. J.B., F.M., S. Kell, and P.W. were employees of Pfizer Inc. at the time of the work and are shareholders of Pfizer Inc. L.S. is a Pfizer consultant after completion of the study and an Employee of Ochsner which received funding from Pfizer to conduct the study. During the AcRIS study, E.K.K. and J.C. were employees of Ochsner Health which received funding from Pfizer to conduct the study and have no financial conflicts of interest to disclose. W.M.R. was an employee of Ochsner Health which received funding from Pfizer to conduct the study and has no financial conflicts of interest to disclose.
